# Intero Biosystems Wins Startup Battlefield

> Intero Biosystems wins TechCrunch's 2026 Startup Battlefield with gut organoids for drug testing.
- Title: Intero Biosystems Wins Startup Battlefield · RuntimeWire
- Summary: Intero Biosystems wins TechCrunch's 2026 Startup Battlefield with gut organoids for drug testing. Intero Biosystems won TechCrunch's 2026 Startup Battlefield…
- Keywords: intero biosystems, techcrunch, startup battlefield, gastroscreen, lab-grown human intestinal models, drug testing, disrupt cup, equity-free funding, fda guidance, technology, Intero, Biosystems
- Source: RuntimeWire — https://runtimewire.com/article/intero-biosystems-wins-startup-battlefield-2026
- Author: RuntimeWire
- Published: 2026-10-16T00:05:54.71+00:00
- Read time: 1 min
- Topics: intero biosystems, techcrunch, startup battlefield, gastroscreen, lab-grown human intestinal models, drug testing, disrupt cup, equity-free funding, fda guidance, technology, ai
## Intero Biosystems Wins Startup Battlefield
Intero Biosystems won TechCrunch's 2026 Startup Battlefield on October 15th, taking the Disrupt Cup and $100,000 in equity-free funding for its lab-grown human intestinal models.
## Company Founded By
The company, founded by Charlie Childs, Madeline Eiken and University of Michigan professor Jason Spence, is selling its GastroScreen organoids to drug, biotech, food and chemical companies for preclinical testing.
## Business Model
Intero has moved beyond a lab concept to paid customers, but its business depends on proving that GastroScreen's results are reproducible and useful against existing animal and clinical data.
## Key takeaway

Intero Biosystems won TechCrunch's 2026 Startup Battlefield on October 15th, taking the Disrupt Cup and $100,000 in equity-free funding for its lab-grown human intestinal models.